SURGE THERAPEUTICS Trademark

Trademark Overview


On Thursday, September 23, 2021, a trademark application was filed for SURGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SURGE THERAPEUTICS trademark a serial number of 97042717. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 27, 2024. This trademark is owned by STIMIT CORPORATION. The SURGE THERAPEUTICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, resp...

Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy

Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website
surge therapeutics

General Information


Serial Number97042717
Word MarkSURGE THERAPEUTICS
Filing DateThursday, September 23, 2021
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Goods and ServicesHydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy
Goods and ServicesArtificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateMonday, November 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, November 14, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSURGE THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBROOKLINE, MA 02446

Party NameSURGE THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBROOKLINE, MA 02446

Party NameSTIMIT CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrookline, MA 02446

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 24, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, January 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, December 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 25, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, August 25, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 30, 2023NON-FINAL ACTION E-MAILED
Friday, June 30, 2023NON-FINAL ACTION WRITTEN
Thursday, June 8, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, November 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 25, 2022LETTER OF SUSPENSION E-MAILED
Friday, November 25, 2022SUSPENSION LETTER WRITTEN
Monday, November 14, 2022EXAMINER'S AMENDMENT ENTERED
Monday, November 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 14, 2022EXAMINERS AMENDMENT E-MAILED
Monday, November 14, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, October 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 21, 2022NON-FINAL ACTION E-MAILED
Thursday, July 21, 2022NON-FINAL ACTION WRITTEN
Friday, June 24, 2022ASSIGNED TO EXAMINER
Wednesday, November 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 27, 2021NEW APPLICATION ENTERED